Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nam H Dang

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 22, 2011
Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II studyBradford S Hoppe, Stella Flampouri, Zhong Su, et al.
Journal of Virology|September 27, 2013
Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibodyKei Ohnuma, Bart L Haagmans, Ryo Hatano, et al.
Experimental Hematology & Oncology|October 13, 2017
Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patientsRohit Bishnoi, Ravneet Bajwa, Aaron J Franke, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2012
Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphomaBradford S Hoppe, Stella Flampouri, Zhong Su, et al.
The Journal of Biological Chemistry|February 9, 2007
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1Kei Ohnuma, Masahiko Uchiyama, Tadanori Yamochi, et al.
Leukemia & Lymphoma|November 3, 2005
Toxic epidermal necrolysis associated with denileukin diftitox (DAB389IL-2) administration in a patient with follicular large cell lymphomaKristel Polder, Chiyu Wang, Madeleine Duvic, et al.
Journal of Drug Assessment|September 30, 2017
Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphomaRandeep Sangha, Andrew Davies, Nam H Dang, et al.
Cureus|May 31, 2021
A Multi-Center Retrospective Analysis Examining the Effect of Dipeptidyl Peptidase-4 Inhibitors on Progression-Free Survival in Patients With Prostate CancerKelsey Pan, William P Skelton, Mohammed Elzeneini, et al.
Cancer|March 17, 2004
Thalidomide for patients with recurrent lymphomaBarbara Pro, Anas Younes, Maher Albitar, et al.
International Journal of Molecular Sciences|August 12, 2023
A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKLShohei Kikuchi, Akinori Wada, Yusuke Kamihara, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|October 22, 2011
Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II studyBradford S Hoppe, Stella Flampouri, Zhong Su, et al.
Journal of Virology|September 27, 2013
Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibodyKei Ohnuma, Bart L Haagmans, Ryo Hatano, et al.
Experimental Hematology & Oncology|October 13, 2017
Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patientsRohit Bishnoi, Ravneet Bajwa, Aaron J Franke, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2012
Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphomaBradford S Hoppe, Stella Flampouri, Zhong Su, et al.
The Journal of Biological Chemistry|February 9, 2007
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1Kei Ohnuma, Masahiko Uchiyama, Tadanori Yamochi, et al.
Leukemia & Lymphoma|November 3, 2005
Toxic epidermal necrolysis associated with denileukin diftitox (DAB389IL-2) administration in a patient with follicular large cell lymphomaKristel Polder, Chiyu Wang, Madeleine Duvic, et al.
Journal of Drug Assessment|September 30, 2017
Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphomaRandeep Sangha, Andrew Davies, Nam H Dang, et al.
Cureus|May 31, 2021
A Multi-Center Retrospective Analysis Examining the Effect of Dipeptidyl Peptidase-4 Inhibitors on Progression-Free Survival in Patients With Prostate CancerKelsey Pan, William P Skelton, Mohammed Elzeneini, et al.
Cancer|March 17, 2004
Thalidomide for patients with recurrent lymphomaBarbara Pro, Anas Younes, Maher Albitar, et al.
International Journal of Molecular Sciences|August 12, 2023
A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKLShohei Kikuchi, Akinori Wada, Yusuke Kamihara, et al.
Pageof 13